Ignite Creation Date:
2024-05-05 @ 5:04 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00387686
Status:
TERMINATED
Last Update Posted:
2013-02-28
First Post:
2006-10-11
Brief Title:
A Phase 23 Multicenter Controlled Trial Of rhBMP-2CPM In Tibial Fractures
Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Organization Data
Organization:
Wyeth is now a wholly owned subsidiary of Pfizer
Class:
INDUSTRY
Study ID:
3100N7-210
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None